Skip to main navigation Skip to search Skip to main content

Therapeutic targeting TFE3 in translocation renal cell carcinoma

Project: Research

Project Details

Description

THERAPEUTIC TARGETING TFE3 IN TRANSLOCATION RENAL CELL CARCINOMA
StatusFinished
Effective start/end date05/5/21 → 08/31/23

Funding

  • US Army Medical Research Acquisition Activity: $221,125.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.